MedTrace Logo

Dexmedetomidine on Post-operative Blood Pressure in Bain Arteriovenous Malformation Embolization

NCT03076099 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-03-09

No results posted yet for this study

Summary

Aim of this trial is to study the effect of Dexmedetomidine on post-operative blood pressure in patients undergoing brain arteriovenous malformation embolization. The patients were randomized allocated to either Dexmedetomidine group or Control group. Patients in Dexmedetomidine group will receive intravenous Dexmedetomidine while the control group will receive normal saline. Post-operative anti-hypertensive drug, Visual analogue score,post-operative analgesics consumption, Quality of Recovery score, Ramsay score, and adverse events were recorded.

Conditions

  • Anesthesia

Interventions

DRUG

Dexmedetomidine

1.2 μg/kg Dexmedetomidine was administered intravenously constantly after tracheal extubation.

OTHER

normal saline

equal volume of normal saline was administered intravenously constantly after tracheal extubation.

Sponsors & Collaborators

  • Nan Jiang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03076099 on ClinicalTrials.gov